Biological effects of oxidant stress in haemodialysis: The possible roles of vitamin E

Blood Purification

Volumn 17, Issue 2-3, 1999, Pages 79-94

  Galli, Francesco ^b   Canestrari, Franco ^c   Buoncristiani, Umberto ^a  

^a Ospedale Silvestrini   (Italy)

^b UNIVERSITY OF URBINO   (Italy)

^c NONE

Author keywords

Antioxidants; Apoptosis; Ascorbic acid; Glutathione; Haemodialysis; Lipid oxidation; Oxidant stress; Oxidative stress; Uremia; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BIOMATERIAL; REACTIVE OXYGEN METABOLITE; UREMIC TOXIN;

APOPTOSIS; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; DIALYSIS MEMBRANE; HEMODIALYSIS; HUMAN; LEUKOCYTE ACTIVATION; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; HUMANS; OXIDATIVE STRESS; RENAL DIALYSIS; VITAMIN E;

EID: 0032805011     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014379     Document Type: Conference Paper

References (71)

1. Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine. Oxford, Oxford University Press, 1989.
2. Rice-Evans CA, Diplock AT: Current status of antioxidant therapy. Free Rad Biol Med 1993; 15:77-96.
3. Diplock AT, Chaleux J-L, Crozier-Willi G, Kok FS, Rice-Evans C, Roberfroid M, Stahl W, Wiña-Ribes J: Functional food sciences and defences against reactive oxygen species. Brit J Nutr 1998;80:S77-S112.
4. Rice-Evans C, Gopinathan V; in Apps DK, Tripton KF (eds): Essays in Biochemistry, London, Portland Press, 1995.
5. Suzuki YJ, Forman HJ, Sevanian A: Oxidants as stimulator of signal transduction. Free Rad Biol Med 1997;22:269-285.
6. Galli F, Bellomo G: Physiopathology of oxidative stress and its implication in hemodialysis patients. Contrib Nephrol, in press.
7. Bellomo G, Thor H, Eklow-Lastbom L, Nicotera P, Orrenius S: Oxidative stress: mechanism of cytotoxicity. Chem Scripta 1987;27A: 117-120.
8. Fernandes RS, Cotter TG: Apoptosis or necrosis: intracellular levels of glutathione influence mode of cell death. Biochem Pharmacol 1994; 48:675-681.
9. Shintani D, DellaPenna D: Elevating the vitamin E content of plants through metabolic engineering. Science 1998;282:2098-2100.
10. Niki E: in Hayaishi O, Mino M (eds): Clinical and Nutritional Aspects of Vitamin E, Amsterdam, Elsevier, 1986, pp 3-14.
11. Redanna P, Whelan J, Burgess JR, Eskew ML, Hildenbrandt G, Zarkower A, Scholz RW, Reddy CC: The role of vitamin E and selenium on arachidonic acid oxidation by way of the 5-lipoxygenase pathway. Ann NY Acad Sci 1989; 570:136-145.
12. Ricciarelli R, Tasinato A, Clement S, Ozer NK, Boscoboinik D, Azzi A: Alpha-tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem J 1998;15:243-249.
13. Galli F, Rovidati S, Chiarantini L, Kulurianu H, Canestrari F, Buoncristiani U: Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter. Kidney Int 1998;54:580-589.
14. Miyata T, Fu MX, Kurokawa K, van Ypersele de Strihou C, Thorpe SR, Baynes JW: Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: Is there oxidative stress in uremia? Kidney Int 1998;54: 1290-1295.
15. Fiorillo C, Oliviero C, Rizzuti G, Nediani C, Pacini A, Nassi P: Oxidative stress and antioxidant defences in renal patients receiving regular haemodialysis. Clin Chem Lab Med 1998; 36:149-153.
16. Roselaar SE, Nazhat NB, Winyard PG, Jones P, Cunningham J, Blake DR: Detection of oxidants in uremic plasma by electron spin resonance spectroscopy. Kidney Int 1995;48:199-206.
17. Hasselwander O, Young IS: Oxidative stress in chronic renal failure. Free Rad Res 1998;29:1-11.
18. Himmelfarb J, Lazarus JM, Hakim R: Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 1991;17:271-276.
19. Dypbukt JM, Ankarcrona M, Burkitt M, Sjoholm A, Strom K, Orrenius S, Nicotera P: Different prooxidant levels stimulate growth, trigger apoptosis, or produce necrosis of insulin-secreting RINm5F cells. J Biol Chem 1994; 269:30553-30560.
20. Giardini O, Taccone-Gallucci M, Lubrano R, Ricciardi-Tenore G, Bandino D, Silvi I, Ruberto U, Casciani CU: Evidence of red blood cell lipid peroxidation in haemodialysis patients. Nephron 1984;36:235-237.
21. Canestrari F, Galli F, Giorgini A, Galiotta P, Pascucci M, Bossu M: Erythrocyte redox state in uremic anemia: effects of hemodialysis and relevance of glutathione metabolism. Acta Haematol 1994;91:187-193.
22. Canestrari F, Buoncristiani U, Galli F, Giorgini A, Albertini MC, Carobi C, Pascucci M, Bossù M: Redox state, antioxidative activity and lipid peroxidation in the erythrocytes and plasma of chronic ambulatorial peritoneal dialysis patients. Clin Chim Acta 1995;234:127-136.
23. Peuchant E, Carbonneau M-A, Dubourg L, thomas MJ, Perromat A, Vallot C, Clerc M: Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: Vitamins A, E and iron status. Free Rad Biol Med 1994;16:339-346.
24. Chan AC, Tran K, Raynor T, Ganz PR, Chow CK: Regeneration of vitamin E in human platelets. J Biol Chem 1991;266:17290-17295.
25. Devaraj S, Li D, Jialal I: The effect of alpha tocopherol supplementation on monocyte function. J Clin Invest 1996;98:756-763.
26. Miki M, Tamai H, Mino M, Yamamoto Y, Niki E: Free-radical chain oxidation of rat red blood cells by molecular oxygen and its inhibition by α-tocopherol. Arch Biochem Biophys 1987;258:373-380.
27. Huysmans K, Lins RL, Daelemans R, Zachée P, De Broe ME: Hypertension and accelerated atherosclerosis in endstage renal disease. J Nephrol 1998;11:185-195.
28. Van Der Vliet A, Bast A: Effect of oxidative stress on receptor and signal transmission. Chem Biol Interactions 1992;85:95-116.
29. Berridge MJ: Inositol triphosphate and calcium: Two interacting second messengers. Am J Neprol 1997;17:1-11.
30. Heidenreich S, Schmidt M, Bachmann J, Harrach B: Apoptosis of monocytes cultured from long-term hemodialysis patients. Kidney Int 1996;49:792-799.
31. Matsumoto Y, Shinzato T, Amano I, Takai I, Kimura Y, Morita H, Miwa M, Nakane K, Yoshikai Y, Maeda K: Relationship between susceptibility to apoptosis and Fas expression in peripheral blood T cells from uremic patients. A possible mechanism for lymphopenia in chronic renal failure. Biochem Biophys Res Commun 1995;215:98-105.
32. Cendoroglo M, Jaber BL, Balakrishnan VS, Perianayagam MC, King AJ, Pereira BJG: Neutrophil apoptosis and dysfunction in uremia. J Am Soc Nephrol 1999;10:93-100.
33. Wyllie AH, Ker JFR, Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 1980;68:251-273.
34. Kerr JFR, Harmon BV; in Tomei LD, Cope FO (eds): Apoptosis: The Molecular Basis of Cell Death. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1991, pp 5-29.
35. Wyllie AH: Apoptosis: cell death in tissue regulation. J Pathol 1987;153:313-316.
36. Parijs LK, Abbas AK: Homeostasis and self-tolerance in the immune system. Turning lymphocytes off. Science 1998;280:243-248.
37. Vanholder R, De Smet R, Waterloos MA, Van Landschoot N, Vogeleere P, Hoste E, Ringoir S: Mechanisms of uremic inhibition of phagocyte reactive species production: Characterization of the role of p-cresol. Kidney Int 1995;47: 510-517.
38. Haag-Weber M, Horl WH: Uremia and infection: mechanisms of impaired cellular host defence. Nephron 1993;125-131.
39. Himmelfarb J, Hakim RM: Biocompatibility and risk of infection in haemodialysis patients. Nephrol Dial Transplant 1994;9:138-144.
40. Lennon SV, Martin SJ, Cotter TG: Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif 1991;24:203-214.
41. Dini L, Coppola S, Ruzittu MT, Ghibelli L: Multiple pathways for apoptotic nuclear fragmentation. Exp Cell Res 1996;223:340-347.
42. Buocristiani U, Galli F, Benedetti S, Errico R, Beninati S, Ghibelli L, Rovidati S, Floridi A, Canestrari F: Quantitative and qualitative assessment and clinical meaning of molecules removed with BK membranes: in Ronco C (ed): PMMA, a flexible membrane for a tailored dialysis. Contrib Nephrol. Basel, Karger, 1998, vol 125, pp 133-158.
43. Ghibelli L, Fanelli C, Rotilio G, Lafavia E, Coppola S, Colussi C, Civitareale P, Ciriolo MR: Rescue from apoptosis by inhibition of active GSH extrusion. FASEB J 1998;12:479-486.
44. Urban JL, Shephard HN, Rothstein JL, Sugarman BJ, Shreiber H: Tumor necrosis factor: A potent effector molecule for tumor cell killing by activated macrophages. Proc Natl Acad Sci USA 1986;83:5233-5237.
45. Ribciro P, Renard N, Warzocha K, Charlot C, Jeandenant L, Callet-Bauchu E, Coiffier B, Salles G: CD40 regulation of death domains containing receptors and their ligands on lymphoma B cells. Br J Haematol 1998;103:684-689.
46. Zeng L, Xia Y, Garcia GE, Hwang D, Wilson CB: Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. J Clin Inv 1995;95: 1669-1675.
47. Shimizu R, Komatsu N, Nakamura Y, Nakauchi H, Nakabeppu Y, Miura Y: Role of c-jun in the inhibition of crythropoietin receptor-mediated apoptosis. Biochem Biophys Res Comm 1996;222:1-6.
48. Sun Y, Oberley LW: Redox regulation of transcriptional activators. Free Rad Biol Med 1996;21:335-348.
49. Gil-Gomez G, Berns A, Brady HJ: A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis. EMBO J 1998;17:7209-7218.
50. Halicka HD, Seiter K, Feldman EJ, et al: Cell cycle specificity of apoptosis during treatment of leukaemias. Apoptosis 1997;2:25-39.
51. Hockenbery DM, Oltvai ZN, Yin XN, Milliman CL, Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75:241-251.
52. Szabo C, Ohshima H: DNA damage induced by peroxynitrite: Subsequent biological effects. Nitric Oxide Biol Chem 1997;1373-385.
53. Nosseri C, Coppola S, Ghibelli L: Possible involvement of poly(ADP-ribosyl)polymerase in triggering stress-induced apoptosis. Exp Cell Res 1994;212:367-373.
54. Malorni W, Rivabene R, Santini MT, Donelli G: N-acetylcysteine inhibits apoptosis and decreases viral particles in HIV-chronically infected U937 cells. FEBS Lett 1993;327:75-78.
55. Sandstrom PA, Roberts B, Folks TM, Butke TM: HIV gene expression enhances T cell susceptibility of hydrogen peroxide-induced apoptosis. AIDS Res Human Retroviruses 1993;9: 1107-1113.
56. Qiu Z-H, Leslie CC: Protein kinase C-dependent and-independent pathways of mitogen-activated protein kinase activation in macrophages by stimuli that activate phospholipase A2. J Biol Chem 1994;269:19480-19487.
57. Carracedo J, Ramirez R, Pintado O, Gomez-Villamandos JC, Martin-Malo A, Rodriguez M, Aljama P: Cell aggregation and apoptosis induced by hemodialysis membranes. J Am Soc Nephrol 1995;6:1586-1591.
58. Carracedo J, Ramirez R, Martin-Malo A, Rodriguez M, Aljama P: Nonbiocompatible hemodialysis membranes induce apoptosis in mononuclear cells: the role of G-proteins. J Am Soc Nephrol:1998;9:46-53.
59. Talley AK, Dewhurst S, Perry S, Dollard SC, Gummuluru S, Fine SM, New D, Epstein LG, Gendelman HE, Gelbard HA: Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the gene bcl-2 and crmA. Mol Cell Biol 1995;15:2359-2366.
60. Zuckerman SH, Evans GF, Guturie L: Transcriptional and post-transcriptional mechanisms involved in the differential expression of LPS-induced IL-1 and TNF mRNA. Immunol 1991;73:460-465.
61. Chan AC: Vitamin E and atherosclerosis. J Nutr 1998;128:1593-1596.
62. Bendich A: Antioxidant vitamins and human immune response; in Litwack G (ed): Vitamins and Hormones. San Diego, Academic Press, 1996, pp 35-62.
63. Hassan MQ, Hussain SA, Zaki MA, Alsharif NZ, Stohs SJ: Protective effects of antioxidants against uraemia-induced lipid peroxidation and glutathione depletion in humans. Pharmacol Toxicol 1995;77:407-411.
64. Zachee P, Ferrant A, Daelemans R, Goossens W, Boogaerts MA, Lins RL: Reduced glutathione for the treatment of anemia during hemodialysis: a preliminary communication. Nephron 1995;71:343-349.
65. Panzetta O, Cominacci L, Garbin U, Fratta Pasini A, Gammaro L. Bianco F, Davoli A, Campagnola M, De Sancis A, Pastorino AM: Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: effects of fish oil and vitamin E administration. Clin Nephrol 1995;44:303-309.
66. Cristol JP, Bosc JY, Badiou S, Leblanc M, Lorrho R, Descomps B, Canaud B: Erythropoietin and oxidative stress in hemodialysis. Beneficial effects of vitamin E supplementation. Nephrol Dial Transplant 1997;12:2312-2317.
67. Costagliola C, Romano L, Scibelli G, de Vincentiis A, Sorice P, Di Benedetto A: Anemia and chronic renal failure: a therapeutical approach by reduced glutathione parenteral administration. Nephron 1992;61:404-408.
68. Usberti M, Lima G, Arisi M, Bufano G, D'Avanzo L, Gazzotti RM: Effect of exogenous reduced glutathione on the survival of red blood cells in hemodialyzed patients. J Nephrol 1997;10:261-265.
69. Wratten ML, Navino C, Tetta C, Verzetti G: Haemolipodialysis. Blood Purif 1999;17:127-133.
70. Buoncristiani U, Galli F, Rovidati S, Albertini MC, Covarelli C, Canestrari F: Oxidative damage during hemodialysis using a vitamin E-modified dialysis membrane: a preliminary characterization. Nephron 1997;77:57-61.
71. Hogg N, Darley-Usmar VM, Wilson MT, Moncada S: The oxidation of α-tocopherol in human low-density lipoprotein by the simultaneous generation of superoxide and nitric oxide. FEBS Lett 1993;326:199-203.